Author and year |
Improvement in liver function tests (ALT, AST, ALP, GGT) |
Improvement in NAFLD Activity Score (NAS) |
Improvement in steatosis |
Improvement in fibrosis score |
Improvement in ballooning |
Improvement in lobular inflammation |
Sanyal et al. 2010 |
Significant reduction in mean AST, ALT, ALP, and GGT levels |
Yes |
Yes |
No |
Yes |
Yes |
Foster et al. 2011 |
No |
Not recorded |
Yes |
Not recorded |
Not recorded |
Not recorded |
Hoofnagle et al. 2013 |
Significant reduction in ALT only |
No |
Yes |
No |
Yes |
Yes |
Aller et al. 2015 |
Significant reduction in GGT only |
Not recorded |
Not recorded |
Yes |
Not recorded |
Not recorded |
Polyzos et al. 2017 |
No |
Not recorded |
No |
No |
Not recorded |
Not recorded |
Pervez et al. 2018 |
Significant reduction in mean AST and ALT in the treatment group |
Not recorded |
No |
Not recorded |
Not recorded |
Yes |
Bril et al. 2019 |
Significant reduction in mean AST and ALT in both treatment groups |
Not recorded |
Yes |
No |
No |
No |
Anushiravani et al. 2019 |
Significant reduction in mean AST and ALT in treatment groups |
Not recorded |
Not recorded |
Not recorded |
Not recorded |
Not recorded |
No. of results showing improvement |
6 |
1 |
4 |
1 |
2 |
3 |
No. of results showing no improvement |
2 |
1 |
2 |
4 |
1 |
1 |
No. of results not recorded |
0 |
6 |
2 |
3 |
5 |
4 |